Latest Aquilo Capital Management, LLC Stock Portfolio
Aquilo Capital Management, LLC Performance:
2024 Q3: -3.63%YTD: -8.09%2023: 16.2%
Performance for 2024 Q3 is -3.63%, and YTD is -8.09%, and 2023 is 16.2%.
About Aquilo Capital Management, LLC and 13F Hedge Fund Stock Holdings
Aquilo Capital Management, LLC is a hedge fund based in SAN FRANCISCO, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $442.5 Millions. In it's latest 13F Holdings report, Aquilo Capital Management, LLC reported an equity portfolio of $131.9 Millions as of 30 Sep, 2024.
The top stock holdings of Aquilo Capital Management, LLC are ARWR, BPMC, KYMR. The fund has invested 11.7% of it's portfolio in ARROWHEAD PHARMACEUTICALS IN and 8.7% of portfolio in BLUEPRINT MEDICINES CORP.
They significantly reduced their stock positions in SILENCE THERAPEUTICS PLC, KYMERA THERAPEUTICS INC (KYMR) and MERUS N V (MRUS). The fund showed a lot of confidence in some stocks as they added substantially to IMMATICS N.V, BICYCLE THERAPEUTICS PLC (BCYC) and BLUEPRINT MEDICINES CORP (BPMC).
The top stock holdings of Aquilo Capital Management, LLC are ARWR, BPMC, KYMR. The fund has invested 11.7% of it's portfolio in ARROWHEAD PHARMACEUTICALS IN and 8.7% of portfolio in BLUEPRINT MEDICINES CORP.
They significantly reduced their stock positions in SILENCE THERAPEUTICS PLC, KYMERA THERAPEUTICS INC (KYMR) and MERUS N V (MRUS). The fund showed a lot of confidence in some stocks as they added substantially to IMMATICS N.V, BICYCLE THERAPEUTICS PLC (BCYC) and BLUEPRINT MEDICINES CORP (BPMC).
Aquilo Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Aquilo Capital Management, LLC made a return of -3.63% in the last quarter. In trailing 12 months, it's portfolio return was 26.69%.
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| immatics n.v | 66.75 |
| bicycle therapeutics plc | 16.09 |
| blueprint medicines corp | 8.73 |
| repare therapeutics inc | 3.39 |
| regenxbio inc | 2.7 |
Additions to existing portfolio by Aquilo Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| silence therapeutics plc | -36.58 |
| kymera therapeutics inc | -36.5 |
| merus n v | -20.43 |
| arrowhead pharmaceuticals in | -12.4 |
| arvinas inc | -9.33 |
Aquilo Capital Management, LLC reduced stake in above stock
Sold off
Sector Distribution
Aquilo Capital Management, LLC has about 89.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 89.2 |
| Others | 10.8 |
Market Cap. Distribution
Aquilo Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 48.1 |
| SMALL-CAP | 26.4 |
| MICRO-CAP | 14.8 |
| UNALLOCATED | 10.8 |
Stocks belong to which Index?
About 70.3% of the stocks held by Aquilo Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 70.3 |
| Others | 29.7 |
Aquilo Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aquilo Capital Management, LLC
Aquilo Capital Management, LLC has 13 stocks in it's portfolio. About 60.2% of the portfolio is in top 10 stocks. ARWR proved to be the most loss making stock for the portfolio. KYMR was the most profitable stock for Aquilo Capital Management, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 2.76 | 2,531,190 | 3,644,920 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 7.26 | 388,766 | 9,575,310 | reduced | -9.33 | ||
| ARWR | arrowhead pharmaceuticals in | 11.69 | 795,813 | 15,414,900 | reduced | -12.4 | ||
| BCYC | bicycle therapeutics plc | 3.12 | 181,911 | 4,116,650 | added | 16.09 | ||
| BPMC | blueprint medicines corp | 8.74 | 124,600 | 11,525,500 | added | 8.73 | ||
| DTIL | precision biosciences inc | 2.59 | 381,803 | 3,420,960 | unchanged | 0.00 | ||
| KYMR | kymera therapeutics inc | 7.49 | 208,743 | 9,879,810 | reduced | -36.5 | ||
| MRUS | merus n v | 4.46 | 117,855 | 5,888,040 | reduced | -20.43 | ||
| RGNX | regenxbio inc | 7.40 | 930,708 | 9,763,130 | added | 2.7 | ||
| RPTX | repare therapeutics inc | 2.58 | 989,364 | 3,403,410 | added | 3.39 | ||
| STRO | sutro biopharma inc | 2.00 | 762,498 | 2,638,240 | unchanged | 0.00 | ||
| silence therapeutics plc | 4.37 | 317,214 | 5,766,950 | reduced | -36.58 | |||
| immatics n.v | 2.89 | 333,502 | 3,805,260 | added | 66.75 | |||